Preparing to Treat Concussions in Hockey Players Using a "From Ice to Axon and Astrocyte Repeated Measures Design"

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 18-004925
    • Scottsdale/Phoenix, Arizona: 18-004925
    Sponsor Protocol Number: 18-004925

About this study

The purpose of this study is to demonstrate the value of our objective diagnosis of concussion (ODC) components and to quantify severity. ODC components include: the NeuroCatch™ Platform [quantified electroencephalogram (qEEG)] developed by NeuroCatch Inc., the King-Devick Test (in association with Mayo Clinic) of rapid number naming, and blood biomarkers such as neurofilament light (NfL), neuron-specific enolase (NSE), and S100B.  Wearable accelerometers (Triax Technologies’ SIM-G, X2 Biosystems X Patch, and Prevent Biometrics’ Impact Monitor Mouthguard) and three camera video footage will also provide acceleration data to correlate to concussive injuries and mechanism of injury. Time on Ice tracking will allow for calculation of Individual Exposure Time (IET).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Consenting Junior A ice hockey players
  • Medically cleared to participate in hockey at the time of enrollment are eligible to participate in this study.

Exclusion Criteria:

  • Any players not medically cleared or for other reasons are restricted from hockey cannot participate in this study.
     

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Michael Stuart, M.D.

Closed for enrollment

Contact information:

Michelle Caputi

7763725

Caputi.Michelle@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Michael Stuart, M.D.

Closed for enrollment

Contact information:

David Dodick M.D.

4803018000

Dodick.David@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20438798

Mayo Clinic Footer